262 related articles for article (PubMed ID: 36240975)
1. Chinese patent medicine Kanglaite injection for non-small-cell lung cancer: An overview of systematic reviews.
Lu T; Yu J; Gao R; Wang J; Wang H; Wang X; Xu B; Cao L; Wu J; Ni B; Li S; Li J
J Ethnopharmacol; 2023 Feb; 302(Pt A):115814. PubMed ID: 36240975
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Shenqi Fuzheng injection combined with chemotherapy for cancer: An overview of systematic reviews.
Chen G; Lu J; Li B; Zhao M; Liu D; Yang Z; Liu F
Phytomedicine; 2024 Mar; 125():155293. PubMed ID: 38295658
[TBL] [Abstract][Full Text] [Related]
3. [Overview of systematic reviews and Meta-analysis of Aidi Injection combined with chemotherapy in treatment of non-small cell lung cancer].
Gui YR; Fan BJ; Li JL; Wang S; Dong J; Hou W
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(14):3923-3932. PubMed ID: 35850851
[TBL] [Abstract][Full Text] [Related]
4. Compound Kushen injection combined with transarterial chemoembolization for hepatocellular carcinoma: An evidence map and overview of systematic reviews.
Lu T; Kong B; Wang Y; Yu J; Pan Y; Chen D; Li H; Chen X; Yuan Z; Yang Z; Zhang J; Ding T; Zhang G; Fan Q; Wang X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117267. PubMed ID: 37838291
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive effect of compound Kushen Injection to chemotherapy for non-small cell lung cancer: An evidence map and overview of systematic reviews.
Yu ZY; Peng RY; Han M; Grant S; Yang GY; Liu JP; Cao HJ
J Ethnopharmacol; 2021 Dec; 281():114538. PubMed ID: 34418510
[TBL] [Abstract][Full Text] [Related]
6. Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial.
Gao R; Zhang Y; Hou W; Li J; Zhu G; Zhang X; Xu B; Wu Z; Wang H
Trials; 2021 Mar; 22(1):214. PubMed ID: 33731199
[TBL] [Abstract][Full Text] [Related]
7. Chinese patent medicine Aidi injection for cancer care: An overview of systematic reviews and meta-analyses.
Yang M; Shen C; Zhu SJ; Zhang Y; Jiang HL; Bao YD; Yang GY; Liu JP
J Ethnopharmacol; 2022 Jan; 282():114656. PubMed ID: 34551361
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of traditional Chinese medicine adjuvant therapy for severe pneumonia: evidence mapping of the randomized controlled trials, systematic reviews, and meta-analyses.
Xie K; Guan S; Jing H; Ji W; Kong X; Du S; Jia M; Wang H
Front Pharmacol; 2023; 14():1227436. PubMed ID: 37841930
[No Abstract] [Full Text] [Related]
9. Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhu G; Wang X; Li J; Zhang Y; Gao R; Zhang X; Xu B; Hu J; Dai M; Chen J
Front Pharmacol; 2021; 12():694129. PubMed ID: 34803667
[No Abstract] [Full Text] [Related]
10. Chinese herbal medicine Ginkgo biloba L. preparations for ischemic stroke: An overview of systematic reviews and meta-analyses.
Meng TT; You YP; Li M; Guo JB; Song XB; Ding JY; Xie XL; Li AQ; Li SJ; Yin XJ; Wang P; Wang Z; Wang BL; He QY
J Integr Med; 2024 Mar; 22(2):163-179. PubMed ID: 38519277
[TBL] [Abstract][Full Text] [Related]
11. Kanglaite Injection Combined with Chemotherapy versus Chemotherapy Alone for the Improvement of Clinical Efficacy and Immune Function in Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Wen J; Yang T; Wang J; Ma X; Tong Y; Zhao Y
Evid Based Complement Alternat Med; 2020; 2020():8586596. PubMed ID: 32047528
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.
Xiao Z; Wang C; Zhou M; Hu S; Jiang Y; Huang X; Li N; Feng J; Tang F; Chen X; Ding J; Chen L; Wang Y; Li X
J Ethnopharmacol; 2019 Jan; 228():110-122. PubMed ID: 30243827
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive effect of compound Kushen injection for cancer: An overview of systematic reviews.
Li C; Niu D; Zhu R; Yan X; Qu H; Zhang Y; Zheng Y
J Ethnopharmacol; 2023 Dec; 317():116778. PubMed ID: 37328082
[TBL] [Abstract][Full Text] [Related]
14. Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs.
Huang X; Wang J; Lin W; Zhang N; Du J; Long Z; Yang Y; Zheng B; Zhong F; Wu Q; Ma W
Phytomedicine; 2020 Feb; 67():153154. PubMed ID: 31926475
[TBL] [Abstract][Full Text] [Related]
15. Chinese herbal medicine xuebijing injection for acute pancreatitis: An overview of systematic reviews.
Zhu F; Yin S; Zhou L; Li Z; Yan H; Zhong Y; Wu X; Luo B; Yang L; Gan D; Deng L; Che D; Li L
Front Pharmacol; 2022; 13():883729. PubMed ID: 36034818
[No Abstract] [Full Text] [Related]
16. Effectiveness and safety of manual therapy for knee osteoarthritis: An overview of systematic reviews and meta-analyses.
Feng T; Wang X; Jin Z; Qin X; Sun C; Qi B; Zhang Y; Zhu L; Wei X
Front Public Health; 2023; 11():1081238. PubMed ID: 36908468
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Huachansu as an Adjuvant Therapy for Non-Small Cell Lung Cancer: An Overview of Systematic Reviews and Meta-Analyses.
Yang T; Wu C; Li P; Zhong Y; Wu W; Wang S; Yang X
Integr Cancer Ther; 2024; 23():15347354241237234. PubMed ID: 38469799
[TBL] [Abstract][Full Text] [Related]
18. Shenqi Fuzheng Injection Combined With Chemotherapy for Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses.
Xu J; Li X; Dong Q; Lv L; Yun Z; Hou L
Integr Cancer Ther; 2023; 22():15347354231210811. PubMed ID: 38006245
[TBL] [Abstract][Full Text] [Related]
19. Benefits and Safety of Chinese Herbal Medicine in Treating Psoriasis: An Overview of Systematic Reviews.
Zhang J; Yu Q; Peng L; Qin Y; Jing M; Huang D; Guo J; Xiao M; Chen M
Front Pharmacol; 2021; 12():680172. PubMed ID: 34276371
[No Abstract] [Full Text] [Related]
20. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
